Glenmark recalls 114 batches of low potassium drug in the US over potentially deadly hyperkalemia risk
Fierce Pharma
JUNE 25, 2024
. | Glenmark Pharmaceuticals on Tuesday said it’s recalling 114 batches of 750mg potassium chloride extended-release capsules thanks to failed dissolution of the product. That side effect can in turn lead to cardiac arrest. That side effect can in turn lead to cardiac arrest.
Let's personalize your content